CAPSTONE INVESTMENT ADVISORS, LLC - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 47 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2016$2,799,000
-72.1%
3,000,000
-72.7%
0.06%
-80.1%
Q1 2016$10,045,00011,000,0000.31%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q2 2016
NameSharesValueWeighting ↓
Alken Asset Management Ltd 850,000$848,0003.53%
TENOR CAPITAL MANAGEMENT Co., L.P. 34,448,000$35,346,0001.72%
Sonora Investment Management, LLC 9,376,000$9,408,0001.12%
CSS LLC/IL 7,500,000$7,639,0000.60%
IRON Financial LLC 490,000$498,0000.31%
MACKAY SHIELDS LLC 32,910,000$33,383,0000.31%
RWC Asset Management LLP 4,550,000$4,642,0000.24%
Opti Capital Management, LP 1,000$1,024,0000.21%
PALISADE CAPITAL MANAGEMENT, LP 4,871,000$4,956,0000.18%
ADVENT CAPITAL MANAGEMENT /DE/ 5,283,000$5,301,0000.12%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders